CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Retrospective evaluation of toceranib phosphate (Palladia) for treatment of different tumor types in 31 dogs
Seo-In Choi, Ye-Lim Nam, Jin-Kyoung Kim, Hyung-Jin Park, Kun-Ho Song, Kyoung Won Seo
Korean J Vet Res. 2021;61(1):e10  Published online March 31, 2021
DOI: https://doi.org/10.14405/kjvr.2021.61.e10

Excel Download

Retrospective evaluation of toceranib phosphate (Palladia) for treatment of different tumor types in 31 dogs
Seo-In Choi, Ye-Lim Nam, Jin-Kyoung Kim, Hyung-Jin Park, Kun-Ho Song, Kyoung Won Seo
Korean Journal of Veterinary Research. 2021;61(1):e10   Crossref logo
Link1 Link2 Link3
Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014–2017)
Margaret L. Musser, Kathryn L. Taikowski, Chad M. Johannes, Philip J. Bergman
BMC Veterinary Research. 2018;14(1):   Crossref logo
Link1 Link2 Link3
Retrospective evaluation of toceranib phosphate (Palladia®) toxicity in cats
C. H. Merrick, J. Pierro, S. E. Schleis, E. A. Sones, Z. M. Wright, R. C. Regan, C. T. Siedlecki, P. J. Bergman
Veterinary and Comparative Oncology. 2016;15(3):710-717   Crossref logo
Link1 Link2 Link3
Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia®) in tumour-bearing dogs: a phase I dose-finding study
X. Pan, K. Tsimbas, I. D. Kurzman, D. M. Vail
Veterinary and Comparative Oncology. 2014;14(2):202-209   Crossref logo
Link1 Link2
Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma
Margaret L. Musser, Chad M. Johannes
BMC Veterinary Research. 2021;17(1):   Crossref logo
Link1 Link2 Link3
Retrospective evaluation of canine heart base tumours treated with toceranib phosphate (Palladia): 2011‐2018
Felicia H. Lew, Bobbi McQuown, Juan Borrego, Suzanne Cunningham, Kristine E. Burgess
Veterinary and Comparative Oncology. 2019;17(4):465-471   Crossref logo
Link1 Link2 Link3 Link4
Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study
C. Robat, C. London, L. Bunting, L. McCartan, N. Stingle, K. Selting, I. Kurzman, D. M. Vail
Veterinary and Comparative Oncology. 2011;10(3):174-183   Crossref logo
Link1 Link2
Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs
Erika P. Berger, Chad M. Johannes, Albert E. Jergens, Karin Allenspach, Barbara E. Powers, Yingzhou Du, Jonathan P. Mochel, Leslie E. Fox, Margaret L. Musser
Journal of Veterinary Internal Medicine. 2018;32(6):2045-2053   Crossref logo
Link1 Link2
Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study
E. Chon, L. McCartan, L. N. Kubicek, D. M. Vail
Veterinary and Comparative Oncology. 2011;10(3):184-193   Crossref logo
Link1 Link2
Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study
R. M. Wouda, S. E. Hocker, M. L. Higginbotham
Veterinary and Comparative Oncology. 2017;16(1):E52-E60   Crossref logo
Link1 Link2